Department of Biology, University of Padua, Padua, Italy.
Eur J Hum Genet. 2013 Nov;21(11):1226-31. doi: 10.1038/ejhg.2013.39. Epub 2013 Mar 13.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary heart muscle disease characterized by progressive myocardial loss, with fibro-fatty replacement, and high frequency of ventricular arrhythmias that can lead to sudden cardiac death. ARVC is a genetically determined disorder, usually caused by point mutations in components of the cardiac desmosome. Conventional mutation screening of ARVC genes fails to detect causative mutations in about 50% of index cases, suggesting a further genetic heterogeneity. We performed a genome-wide linkage study and a copy number variations (CNVs) analysis, using high-density SNP arrays, in an ARVC family showing no mutations in any of the desmosomal genes. The CNVs analysis identified a heterozygous deletion of about 122 kb on chromosome 12p11.21, including the entire plakophilin-2 gene and shared by all affected family members. It was not listed on any of available public CNVs databases and was confirmed by quantitative real-time PCR. This is the first SNP array-based genome-wide study leading to the identification of a CNV segregating with the disease phenotype in an ARVC family. This result underscores the importance of performing additional analysis for possible genomic deletions/duplications in ARVC patients without point mutations in known disease genes.
致心律失常性右室心肌病(ARVC)是一种原发性心肌疾病,其特征为进行性心肌丧失,伴纤维脂肪替代,室性心律失常发生率高,可导致心源性猝死。ARVC 是一种由心脏桥粒成分的点突变引起的遗传性疾病。在大约 50%的索引病例中,常规的 ARVC 基因突变筛查未能检测到致病突变,这表明存在进一步的遗传异质性。我们对一个 ARVC 家族进行了全基因组连锁研究和拷贝数变异(CNVs)分析,使用了高密度 SNP 芯片,该家族中的任何桥粒基因均未发生突变。CNVs 分析发现 12 号染色体 12p11.21 上存在约 122kb 的杂合性缺失,包括整个桥粒斑蛋白-2 基因,所有受影响的家族成员均存在该缺失。该缺失未被列入任何现有的公共 CNVs 数据库,并通过实时定量 PCR 得到了验证。这是首例 SNP 芯片全基因组研究,确定了与 ARVC 家族疾病表型共分离的 CNV。这一结果强调了在已知疾病基因无点突变的 ARVC 患者中,进行额外的基因组缺失/重复分析的重要性。